Back to Search
Start Over
Cell Sheet Technology for Heart Failure
- Source :
- Current Pharmaceutical Biotechnology. 14:61-66
- Publication Year :
- 2013
- Publisher :
- Bentham Science Publishers Ltd., 2013.
-
Abstract
- Heart failure is a life threatening disorder in worldwide and many papers reported about myocardial regeneration through surgical method induced by LVAD, cellular cardiomyoplasty (cell injection), tissue cardiomyoplasty (bioengineered cardiac graft implantation), in situ engineering (scaffold implantation), and LV restrictive devices. Some of these innovated technologies have been introduced to clinical settings. This review article provides summary about recent basical and clinical advances about myocardial regeneration induced by bioengineered cardiac tissue.
- Subjects :
- Heart Failure
medicine.medical_specialty
Tissue Engineering
business.industry
medicine.medical_treatment
Regeneration (biology)
Pharmaceutical Science
medicine.disease
Review article
Surgical methods
Tissue engineering
Heart failure
Internal medicine
Cellular cardiomyoplasty
Cardiology
Animals
Humans
Regeneration
Medicine
Myocytes, Cardiac
business
Myoblasts, Cardiac
Cell sheet
Cardiomyoplasty
Biotechnology
Subjects
Details
- ISSN :
- 13892010
- Volume :
- 14
- Database :
- OpenAIRE
- Journal :
- Current Pharmaceutical Biotechnology
- Accession number :
- edsair.doi.dedup.....292a9671cdc2e7122754a883f794159a